CD38 and Miyoshi myopathy: In vitro incubation with ricolinostat increased CD38 expression on MM cells as evaluated by flow cytometry from 13.4% at baseline to 24.4% after 24 h and 38.0% after 48 h (corresponding to a 1.5- and 2.3-fold increase in MFI; Supplementary Fig. 10).